STAT22h
FDA cuts may mean even less oversight of pet food
More than 102 million U.S. households own a dog or a cat, and thousands more have fish, birds, or reptiles. The resulting pet ...
Fierce Biotech3d
Federal judge blocks FDA's regulation of lab-developed tests
A federal judge in Texas has blocked the FDA’s plans to bring laboratory-developed tests under the same regulations it uses ...
Opinion
Food Safety News4dOpinion
New priorities require resources, expertise, and regulations: Where will they come from?
By Steven Grossman Secretary Kennedy’s announcement came last Thursday: FDA’s contribution to the pending HHS reduction in force (RIF) would ...
Fierce Pharma2d
For struggling cell and gene therapy field, Peter Marks' FDA exit adds even more uncertainty
The sudden resignation of Peter Marks, M.D., Ph.D., from the FDA branch that regulates biological products for humans ...
MedTech Dive3d
Texas judge overturns FDA’s lab developed test regulation, siding with industry groups
The judge vacated the FDA’s final rule, which was strongly opposed by the laboratory industry, and remanded the matter to HHS ...
Occupational Health & Safety12d
Navigating the Challenges of Cold Chain Compliance: Health and Safety Regulations
Maintaining cold chain compliance is crucial for protecting product integrity, worker safety, and minimizing costs, while ...
JD Supra11d
FDA Update: Current Guidelines for Semaglutide and Tirzepatide Compounding
Weight loss clinics, telehealth companies, physicians, and pharmacies that have been prescribing or dispensing compounded GLP ...
360Dx3d
Future of LDT Oversight Unclear Following Court's Rejection of FDA Rule
The ruling makes clear that the FDA lacks the legal authority to regulate LDTs, and observers suggest it could also call into question its authority in other areas.
Food Engineering11d
FDA to Extend Compliance Date for Food Traceability Rule
The agency says entities well positioned to meet the original January 2026 compliance deadline have expressed concern about ...
News-Medical.Net on MSN13d
Healthcare groups urge FDA to act on compounding regulations after GLP-1 medicine shortages
Today, the Obesity Action Coalition (OAC) and The Obesity Society (TOS) sent a letter to the U.S. Food & Drug Administration (FDA), along with more than 20 leading organizations and providers across ...